Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial

Published:2022-04-01 Issue:3 Volume:32 Page:132-142
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Saito Takuya¹,Ishida Mitsuhiro²,Nishiyori Atsushi²,Ochiai Toshimitsu³,Katagiri Hideaki⁴,Matsumoto Hideo⁵

Affiliation:

1. Department of Child and Adolescent Psychiatry, Faculty of Medicine, Hokkaido University, Sapporo, Japan.

2. Project Management Department, Shionogi & Co., Ltd., Osaka, Japan.

3. Biostatistics Center, Shionogi & Co., Ltd., Osaka, Japan.

4. Neuroscience and Pain Products, Bio-Medicines and Clinical Pharmacology Medical, Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan.

5. Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2021.0104

Reference37 articles.

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed., Text Revision. Washington, DC: American Psychiatric Association; 2013.

2. A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder

3. Psychoeducational interventions in adolescent depression: A systematic review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder;Journal of Child and Adolescent Psychopharmacology;2023-12-01

2. Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder;Drug Metabolism and Pharmacokinetics;2023-08

4. EFFECT OF DULOXETINE ON PAIN RELIEF IN PATIENTS UNDERGOING ARTHROPLASTY SURGERY: A SYSTEMATIC REVIEW;GOMAL J MED SCI;2022